Sight Sciences, Inc. SGHT
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2021-07-15
Sight Sciences, Inc. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Encrantz Staffan | director | 2026-06-10 | Buy | 14,100 | $4.88 |
| Fountain Tamara | director | 2026-06-04 | Grant | 28,261 | — |
| Encrantz Staffan | director | 2026-06-04 | Grant | 28,261 | — |
| Burbach Gerhard F | director | 2026-06-04 | Grant | 28,261 | — |
| Zurbay Donald | director | 2026-06-04 | Grant | 28,261 | — |
| Mazzacco Catherine | director | 2026-06-04 | Grant | 28,261 | — |
| Bauerlein Alison | Chief Operating Officer | 2026-05-18 | Sell | 12,728 | $5.12 |
| Rodberg James | Chief Financial Officer | 2026-04-06 | Sell | 7,231 | $3.55 |
Source: SEC EDGAR filings · CIK 0001531177 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.